Green Alpha Advisors, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Green Alpha Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	BUY	$31.23 - $42.99 $624 - $859	20 Added 0.24%	8,414 $284,000
Q4 2023 Jan 04, 2024	SELL	$17.71 - $32.97 $232,780 - $433,357	-13,144 Reduced 61.03%	8,394 $264,000
Q3 2023 Oct 10, 2023	SELL	$25.44 - $37.35 $58,054 - $85,232	-2,282 Reduced 9.58%	21,538 $550,000
Q2 2023 Jul 06, 2023	SELL	$23.94 - $32.36 $14,723 - $19,901	-615 Reduced 2.52%	23,820 $683,000
Q1 2023 Apr 06, 2023	BUY	$14.72 - $23.97 $14,631 - $23,826	994 Added 4.24%	24,435 $585,000
Q4 2022 Jan 12, 2023	BUY	$14.14 - $23.06 $1,117 - $1,821	79 Added 0.34%	23,441 $0
Q3 2022 Oct 14, 2022	SELL	$13.05 - $22.13 $690,188 - $1.17 Million	-52,888 Reduced 69.36%	23,362 $346,000
Q2 2022 Jul 08, 2022	BUY	$12.26 - $31.17 $652,685 - $1.66 Million	53,237 Added 231.33%	76,250 $1.2 Million
Q1 2022 Apr 19, 2022	BUY	$17.64 - $39.57 $36,408 - $81,672	2,064 Added 9.85%	23,013 $620,000
Q4 2021 Jan 12, 2022	BUY	$34.2 - $47.56 $24,829 - $34,528	726 Added 3.59%	20,949 $775,000
Q3 2021 Oct 12, 2021	BUY	$27.88 - $58.25 $58,575 - $122,383	2,101 Added 11.59%	20,223 $966,000
Q2 2021 Jul 22, 2021	BUY	$25.79 - $42.11 $467,366 - $763,117	18,122 New	18,122 $613,000

186

25.9M

320K

153K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $585M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Green Alpha Advisors, LLC with notifications on news.